You just read:

Britannia Pharmaceuticals: Landmark Apomorphine Study Confirms its Established Role as a Highly Effective Treatment for Parkinson's Disease Patients Whose Symptoms Cannot be Controlled on Standard Therapies

News provided by

Britannia Pharmaceuticals Ltd

Apr 25, 2017, 17:51 ET